Edition:
United States

Coloplast A/S (COLOb.CO)

COLOb.CO on Copenhagen Stock Exchange

493.60DKK
20 Feb 2017
Change (% chg)

-- (--)
Prev Close
kr.493.60
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
311,165
52-wk High
kr.540.00
52-wk Low
kr.428.00

COLOb.CO

Chart for COLOb.CO

About

Coloplast A/S is a Denmark-based company active within the healthcare sector. It is engaged in the development, marketing and sale of intimate healthcare products and services, targeting people with diseases of private and personal nature. Its operations are structured into four business areas: Ostomy Care offering products for... (more)

Overall

Beta: 0.88
Market Cap(Mil.): kr.97,475.40
Shares Outstanding(Mil.): 198.00
Dividend: 9.00
Yield (%): 2.74

Financials

  COLOb.CO Industry Sector
P/E (TTM): 31.96 34.11 29.39
EPS (TTM): 15.40 -- --
ROI: 65.76 12.43 13.06
ROE: 79.22 14.41 14.19

UPDATE 1-Coloplast CFO sees pick-up in U.S. sales

* First-quarter sales growth was negatively affected by inventory reductions at large distributors in the United States, but inventory levels are now back to normal, the firm said in a statement

Feb 01 2017

BRIEF-Coloplast Q1 EBIT DKK 1.23 bln, in line with expectations

* Q1 revenue 3.76 billion Danish crowns ($545 million)(Reuters poll 3.76 billion crowns)

Feb 01 2017

BRIEF-Coloplast reaches milestone in South Korea

* Government of South Korea will be improving subsidies to country's catheter users after turn of year

Nov 29 2016

Coloplast's UK business thrives again, but weak pound hurts -CFO

COPENHAGEN, Nov 2 Coloplast's British operations are thriving again after some difficult years, but the weak pound hurts the bottom line for the Danish healthcare maker, chief financial officer Anders Lonning-Skovgaard said.

Nov 02 2016

BRIEF-Coloplast FY EBIT dented by $112 mln provisions for U.S lawsuit

* Says full-year EBIT was impacted by a provision of 750 million Danish crowns ($111.89 million) to cover potential settlements and costs in connection with lawsuits in the United States

Nov 02 2016

BRIEF-Coloplast Q4 EBIT ex-items DKK 1.28 bln, slightly below expectatons

* Q4 revenue 3.74 billion Danish crowns ($557 million)(Reuters poll 3.80 billion crowns)

Nov 02 2016

BRIEF-Coloplast introduces new wound dressing as part of growth ambition

* Says Coloplast introduces new silicone wound dressings as part of growth ambition.

Sep 26 2016

BRIEF-Kristian Villumsen sells and buys shares in Coloplast

* Kristian Villumsen, Executive Vice President, sold 60,000 shares in Coloplast at 504.08 Danish crowns ($76.24) per share

Sep 07 2016

More From Around the Web

Earnings vs. Estimates